BioNTech may be at least 32 times less effective in handling the new Omicron variant, a new study has found. Photo: May Tse
Coronavirus: BioNTech vaccine could be much less effective against Omicron, Hong Kong research team finds
- Inoculation remains only effective way to protect against Covid-19, university researchers say, urging elderly and other high-risk groups to get booster shots
- Little known so far about new variant’s severity, though early data from South Africa shows low rate of hospitalisation
Topic |
Coronavirus pandemic
BioNTech may be at least 32 times less effective in handling the new Omicron variant, a new study has found. Photo: May Tse
